- Home
- BLCO vs PCVX Comparison
BLCO vs PCVX Comparison
Compare BLCO & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLCO
- PCVX
- Stock Information
- Founded
- BLCO 1853
- PCVX 2013
- Country
- BLCO Canada
- PCVX United States
- Employees
- BLCO N/A
- PCVX N/A
- Industry
- BLCO Ophthalmic Goods
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- BLCO Health Care
- PCVX Health Care
- Exchange
- BLCO Nasdaq
- PCVX Nasdaq
- Market Cap
- BLCO 4.9B
- PCVX 4.0B
- IPO Year
- BLCO 2022
- PCVX 2020
- Fundamental
- Price
- BLCO $15.01
- PCVX $33.02
- Analyst Decision
- BLCO Hold
- PCVX Strong Buy
- Analyst Count
- BLCO 11
- PCVX 8
- Target Price
- BLCO $15.80
- PCVX $135.00
- AVG Volume (30 Days)
- BLCO 483.2K
- PCVX 1.5M
- Earning Date
- BLCO 10-29-2025
- PCVX 11-04-2025
- Dividend Yield
- BLCO N/A
- PCVX N/A
- EPS Growth
- BLCO N/A
- PCVX N/A
- EPS
- BLCO N/A
- PCVX N/A
- Revenue
- BLCO $4,891,000,000.00
- PCVX N/A
- Revenue This Year
- BLCO $8.27
- PCVX N/A
- Revenue Next Year
- BLCO $5.73
- PCVX N/A
- P/E Ratio
- BLCO N/A
- PCVX N/A
- Revenue Growth
- BLCO 8.81
- PCVX N/A
- 52 Week Low
- BLCO $10.45
- PCVX $27.66
- 52 Week High
- BLCO $21.69
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- BLCO 62.34
- PCVX 55.75
- Support Level
- BLCO $14.53
- PCVX $30.89
- Resistance Level
- BLCO $15.08
- PCVX $32.32
- Average True Range (ATR)
- BLCO 0.33
- PCVX 1.19
- MACD
- BLCO 0.00
- PCVX 0.30
- Stochastic Oscillator
- BLCO 92.22
- PCVX 84.68
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.